Phase 3 Safety Comparisons for 1.0% Azithromycin in Polymeric Mucoadhesive Eye Drops Versus 0.3% Tobramycin Eye Drops for Bacterial Conjunctivitis

Investigative Ophthalmology and Visual Science- United States

doi 10.1167/iovs.06-1413

Full Text

Abstract

Available in

Date

Authors

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Related search

Efficacy and Safety of Azithromycin 1.5% Eye Drops in Paediatric Population With Purulent Bacterial Conjunctivitis

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2014English

Corticosteroid Eye-Drops

BMJ
1964English

Eye-Drops in Tonometry

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1964English

Safety of 20% Serum Eye Drops In-House Prescription

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2017English

Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye

Journal of Ocular Pharmacology and Therapeutics
OphthalmologyPharmacology
2018English

Contrast Sensitivity and Eye Drops

Open Journal of Ophthalmology
2012English

How to Administer Eye Drops and Eye Ointment

Nursing standard (Royal College of Nursing (Great Britain) : 1987)
Medicine
2016English

Evaluation of the Safety of 2.0% Ganciclovir Eye Drops for Hospital Preparation

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2018English

Efficacy and Safety of Autologous Serum Eye Drops in Treatment of Severe Dry Eye

IOSR Journal of Dental and Medical Sciences
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy